China Meheco Group Co

China Meheco Group Co Current Assets

The Current Assets of China Meheco Group Co (600056.SS) as of Oct 23, 2026 is 6.31 B CNY. In the previous year, Current Assets was 26.60 B CNY — a change of -76.29% (lower).

Current Assets

6.31 BCNY

YoY

-76.29%

Last updated:

Current Assets of China Meheco Group Co is 2025 6.31 B CNY. Current Assets of China Meheco Group Co was 2024 26.60 B CNY. It decreases by -76.29% lower compared to the previous year.

The China Meheco Group Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
22.31 B CNY
Jan 1, 2019
24.51 B CNY
Jan 1, 2020
26.79 B CNY
Jan 1, 2021
23.30 B CNY
Jan 1, 2022
28.19 B CNY
Jan 1, 2023
28.53 B CNY
Jan 1, 2024
26.60 B CNY
Jan 1, 2025
6.31 B CNY
The China Meheco Group Co Current Assets history
YEARCurrent AssetsYoY
6.31 BCNY-76.29%
26.60 BCNY-6.76%
28.53 BCNY+1.18%
28.19 BCNY+21.00%
23.30 BCNY-13.03%
26.79 BCNY+9.31%
24.51 BCNY+9.89%
22.31 BCNY+18.62%
18.80 BCNY+8.65%
17.31 BCNY+21.26%
14.27 BCNY+19.73%
11.92 BCNY+13.70%
10.48 BCNY+16.11%
9.03 BCNY+25.32%
7.20 BCNY+28.25%
5.62 BCNY-0.46%
5.64 BCNY+140.76%
2.34 BCNY+18.95%
1.97 BCNY+34.07%
1.47 BCNY+7.23%
1.37 BCNY+185.35%
480.44 MCNY-39.88%
799.07 MCNY-1.70%
812.88 MCNY-20.26%
1.02 BCNY-3.00%
1.05 BCNY+25.72%
836.00 MCNY+21.82%
686.25 MCNY+51.10%
454.17 MCNY+52.82%
297.19 MCNY+8.62%
273.60 MCNY-9.06%
300.86 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

Current Assets of China Meheco Group Co is 6.31 B CNY in 2025.

Current Assets of China Meheco Group Co changed from 26.60 B CNY to 6.31 B CNY, representing a -76.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's China Meheco Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — China Meheco Group Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — China Meheco Group Co